Presentation Information
[O-04-2]Lambert-Eaton myasthenia syndrome associated with immune checkpoint inhibitor
Hiroki Maesaka1, Yosuke Eguchi2, Shungo Imai3, Masakatsu Motomura4, Shigeaki Suzuki5, Shunya Nakane1, Yuji Nakatsuji1 (1.Department of Neurology, Faculty of Medicine, University of Toyama, Japan, 2.Respiratory Medicine, Bellland General Hospital, Japan, 3.Division of Drug Informatics, Faculty of Pharmacy, Keio University, Japan, 4.Medical Engeneering Course, Nagasaki Institute of Applied Science, Japan, 5.Department of Neurology, Keio University School of Medicine, Japan)